Litcius/Paper detail

Activity of mRNA COVID-19 vaccines in patients with lymphoid malignancies

Jennifer L. Crombie, Amy C Sherman, Chi‐An Cheng, Christine E. Ryan, Rebecca L. Zon, Michaël Desjardins, Peter Baker, Mikaela M. McDonough, Natalie Izaguirre, Bruce Bausk, Jonathan Krauß, Tal Gilboa, Yasmeen Senussi, David R. Walt, Matthew S. Davids, Jennifer R. Brown, Philippe Armand, Lindsey R. Baden, Nicolas C. Issa

2021Blood Advances24 citationsDOIOpen Access PDF

Topics & Concepts

Coronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakVirologyMessenger RNAMedicineImmunologyBiologyInternal medicineGeneGeneticsInfectious disease (medical specialty)OutbreakDiseaseSARS-CoV-2 and COVID-19 ResearchCOVID-19 and healthcare impactsCancer Immunotherapy and Biomarkers
Activity of mRNA COVID-19 vaccines in patients with lymphoid malignancies | Litcius